SUZANNE WARE: Open Payments
NPI 1265549083 · BRADENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$288 in 14 payments from 6 companies in 2025. Trend: 2023 $257 · 2024 $413 · 2025 $288
Food & beverage: $288
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 5 | $95 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Novo Nordisk Inc | 2 | $46 |
| Sumitomo Pharma America, Inc. | 2 | $46 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Amgen Inc. | 1 | $24 |
Products named: TRELEGY ELLIPTA, GEMTESA, BREZTRI, AUSTEDO XR, REPATHA, Wegovy, Ozempic, AIRSUPRA.
Industry payments across FL — which companies pay providers there.
